Incrementally deepening the cellular level of our analysis, we next identified that both classical CD14+CD16- and intermediate CD14+CD16+ monocyte populations contributed to the dysregulated M/L ratio in ATB patients, with increased frequency at diagnosis and a reduction upon initiation of anti-TB therapy. The gene discussed is FCGR3A; the disease is tuberculosis.